ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Imunon Inc

Imunon Inc (IMNN)

1.2583
0.0083
( 0.66% )
Updated: 10:57:27

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
1.2583
Bid
1.21
Ask
1.29
Volume
49,610
1.215 Day's Range 1.44
0.48 52 Week Range 2.00
Market Cap
Previous Close
1.25
Open
1.22
Last Trade
25
@
1.255
Last Trade Time
10:57:27
Financial Volume
$ 62,376
VWAP
1.2573
Average Volume (3m)
32,466
Shares Outstanding
9,400,889
Dividend Yield
-
PE Ratio
-0.59
Earnings Per Share (EPS)
-2.08
Revenue
-
Net Profit
-19.52M

About Imunon Inc

Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the body's natural mechanisms to gen... Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. Show more

Sector
Pharmaceutical Preparations
Industry
Health Care Diversified
Website
Headquarters
Dover, Delaware, USA
Founded
1982
Imunon Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker IMNN. The last closing price for Imunon was $1.25. Over the last year, Imunon shares have traded in a share price range of $ 0.48 to $ 2.00.

Imunon currently has 9,400,889 shares outstanding. The market capitalization of Imunon is $11.75 million. Imunon has a price to earnings ratio (PE ratio) of -0.59.

IMNN Latest News

IMUNON Announces Database Lock for Phase 2 OVATION 2 Study with IMNN-001 in Advanced Ovarian Cancer

Novel IL-12 Immunotherapy Administered with Standard of Care as First-Line Treatment Expects topline results by the end of July LAWRENCEVILLE, N.J., June 24, 2024 (GLOBE NEWSWIRE) -- IMUNON...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.1417-10.12142857141.41.531.215675471.34395849CS
40.138312.34821428571.121.531.1013369901.34433237CS
12-0.0417-3.207692307691.31.571.03324661.33895665CS
260.698124.5761199360.560320.481293841.21265396CS
520.02832.300813008131.2320.48808021.14725588CS
156-0.7017-35.80102040821.9620.48664041.24873204CS
260-0.7017-35.80102040821.9620.48664041.24873204CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NUZENuZee Inc
$ 3.09
(200.00%)
75.59M
SLNASelina Hospitality PLC
$ 0.0565
(117.31%)
606.25M
DRMADermata Therapeutics Inc
$ 2.6201
(101.55%)
51.89M
CREVCarbon Revolution Public Ltd
$ 10.82
(73.95%)
150.55k
BBLGBone Biologics Corporation
$ 2.1068
(68.54%)
32.63M
NXTTNext Technology Holding Inc
$ 2.42
(-58.42%)
249.03k
NUWENewellis Inc
$ 2.59
(-37.59%)
673.16k
ATPCAgape ATP Corporation
$ 0.1414
(-34.23%)
3.99M
VWEVintage Wine Estates Inc
$ 0.0799
(-28.60%)
16.38M
CONNConns Inc
$ 0.38
(-25.05%)
2.1M
SLNASelina Hospitality PLC
$ 0.05655
(117.50%)
606.26M
SGMOSangamo Therapeutics Inc
$ 0.5731
(42.81%)
166.21M
NVDANVIDIA Corporation
$ 117.91
(-3.82%)
77.28M
NUZENuZee Inc
$ 3.03
(194.17%)
75.6M
TSLATesla Inc
$ 218.0901
(-11.48%)
73.73M

Your Recent History

Delayed Upgrade Clock